ASC

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of PSQ Holdings, Inc. - PSQH

Retrieved on: 
Friday, March 15, 2024
Prior, Classification, News, LLP, WalletHub, Security (finance), Business analyst, Bank statement, ASC, Pomerantz, PSQ

NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PSQ Holdings, Inc. (“PSQ” or the “Company”) (NYSE: PSQH).

Key Points: 
  • NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of PSQ Holdings, Inc. (“PSQ” or the “Company”) (NYSE: PSQH).
  • The investigation concerns whether PSQ and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.
  • The Firm has recovered billions of dollars in damages awards on behalf of class members.

ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate in a Panel Discussion Titled “Inflammation Illuminated,”at Benzinga’s Virtual Healthcare Summit 2024 on March 20, 2024

Retrieved on: 
Thursday, March 14, 2024
Inflammasome, Obesity, Entrepreneurship, Multiple sclerosis, Inflammation, Death, NLRP3, World Health Organization, ASC, Therapy, Atherosclerosis, Drug development, Pharmaceutical industry

According to the World Health Organization, 3 of 5 people worldwide die due to chronic inflammatory diseases, which are considered the most significant cause of death in the world.

Key Points: 
  • According to the World Health Organization, 3 of 5 people worldwide die due to chronic inflammatory diseases, which are considered the most significant cause of death in the world.
  • WESTON, Fla., March 14, 2024 (GLOBE NEWSWIRE) -- ZyVersa Therapeutics, Inc. (Nasdaq: ZVSA, or “ZyVersa”), a clinical stage specialty biopharmaceutical company developing first-in-class drugs for the treatment of inflammatory and renal diseases with high unmet medical needs, announces that Stephen C. Glover, Co-Founder, Chairman, Chief Executive Officer, and President, will participate in a panel discussion titled “Inflammation Illuminated,” at Benzinga’s Virtual Healthcare Summit 2024.
  • He will also address new innovations in drug development to alleviate damaging inflammation.
  • Details regarding Mr. Glover’s panel discussion are as follows:

InfuSystem Receives Notice from NYSE American Regarding Late Filing of Annual Report on Form 10-K

Retrieved on: 
Wednesday, April 3, 2024
Medical Supplies, Medical Devices, Health, Practice Management, Other Health, General Health, Exchange, The, Classification, Security (finance), ASC, Annual report, File, Accounting, Delinquent, Medical device

In accordance with Section 1007 of the Company Guide, the Company will have six months from the date of the Filing Delinquency (the "Initial Cure Period"), to file the Delinquent Report with the SEC.

Key Points: 
  • In accordance with Section 1007 of the Company Guide, the Company will have six months from the date of the Filing Delinquency (the "Initial Cure Period"), to file the Delinquent Report with the SEC.
  • The Exchange will monitor the Company and the status of the Delinquent Report and any subsequent delayed filings, including through contact with the Company, until the Filing Delinquency is cured.
  • If the Company fails to file the Delinquent Report during the Initial Cure Period, the Exchange may, in its sole discretion, grant an up to six-month additional cure period (the "Additional Cure Period").
  • There can be no assurance that the Company will ultimately regain compliance with all applicable Exchange listing standards.

Countdown to the Finals of the ASC24 Student Supercomputer Challenge!

Retrieved on: 
Tuesday, April 2, 2024
Research, Apps, Applications, Technology, Oil, Gas, Software, Energy, Hardware, University, Science, Education, Peking University, Shanghai Jiao Tong University, Algorithm, Southwest Petroleum University, Shanghai University, Overalls, Student, LLM, Huachung University, ASC, Water, University of Erlangen–Nuremberg, Lanzhou University, Chinese, National university

The focal point of the ASC24 finals will revolve around tackling cutting-edge scientific issues, such as advancing large language models (LLM), exploring Mars, and enhancing techniques for oil and gas exploitation.

Key Points: 
  • The focal point of the ASC24 finals will revolve around tackling cutting-edge scientific issues, such as advancing large language models (LLM), exploring Mars, and enhancing techniques for oil and gas exploitation.
  • Alongside the primary challenges, the finals will include a Group Competition aimed at fostering cross-team collaboration among students.
  • Numerous new teams are set to join the finals, with Shanghai University, Lanzhou University, and Southern University of Science and Technology among them.
  • The enthusiasm of these new contenders promises to elevate the competition, ensuring an intense battle until the very end.

Henry Schein Completes Acquisition of Majority Interest of TriMed, Inc.

Retrieved on: 
Thursday, April 4, 2024
Medical Devices, Health, Dental, Physical Therapy, Managed Care, Partnership, Patient, Foot, Sale, Acquisition, Ankle, MD, ASC, Extremities, Internationalized domain name, Wrist, Outpatient surgery

Henry Schein announced the agreement to acquire a majority interest of TriMed on December 20, 2023.

Key Points: 
  • Henry Schein announced the agreement to acquire a majority interest of TriMed on December 20, 2023.
  • The addition of TriMed will strengthen Henry Schein’s deep and longstanding relationship with existing Integrated Delivery Networks (IDNs) and Ambulatory Surgery Center (ASC) customers by providing a wider range of surgical solutions.
  • This reflects the Company’s strategy to expand the sale of Henry Schein-owned brands to new and existing customers.
  • Henry Schein expects the transaction to be neutral to 2024 non-GAAP earnings per share and accretive thereafter.

SOFTRAX Named 2024 SIIA CODiE Award Finalist in Best Subscription Billing Solution

Retrieved on: 
Thursday, March 28, 2024
Data Management, Accounting, Technology, Professional Services, Business, Small Business, Data Analytics, Software, Other Professional Services, Internet, Finance, Automation, Education, Innovation, Communication, Educational technology, SIIA, SVP, Publishing, ASC, Allocation, Property management

SOFTRAX, a leading provider of cloud-based billing and revenue management solutions, today announced that the SOFTRAX Revenue Management System was named a 2024 SIIA CODiE Award Finalist in the Best Subscription Billing Solution category.

Key Points: 
  • SOFTRAX, a leading provider of cloud-based billing and revenue management solutions, today announced that the SOFTRAX Revenue Management System was named a 2024 SIIA CODiE Award Finalist in the Best Subscription Billing Solution category.
  • The SOFTRAX Revenue Management System meets the needs of today’s business models by handling all forms of billing, renewal management, and revenue recognition for B-to-B organizations.
  • Today’s companies still need these features to manage legacy business models, but also seek support for complex subscription and consumption billing models in one package.
  • “SOFTRAX is honored to be selected as a finalist for the 2024 CODiE Awards for Best Subscription Billing Solution,” said Tom Zauli, SVP and General Manager at SOFTRAX.

Enterprise Connect 2024 Brought the Enterprise Communications and Customer Experience Community Together to Improve Business Communications/CX

Retrieved on: 
Thursday, March 28, 2024
Software, Networks, Other Communications, Public Relations, Investor Relations, Data Management, Communications, Technology, Other Technology, Diamond, Theta, Jabra, AVAYA, AT&T, Labs, Learning, Unified communications management, CX, TransUnion, Enterprise, CallMiner, Goto, Zoom, Spotlight Awards, USAN, Telefónica, Emulator, Lunch, Cisco Webex, TD SYNNEX, Microsoft, Intrado, Cyber, BICS, Communication, ZOOM, IRIS, Medtronic, RingCentral, AWS, Uniphore, Woman, ViewSonic, Cargill, Exhibition, Singlewire Software, Gold, RSI, HP, Continuant, Organization, XTEN, Poly, AI, Cisco, Amazon Web Services, ASC, Security, Light-year, Syniverse, Consultant, Silver, Verizon Business, UC, AudioCodes, Motus, Electronics, Charter Communications, Ecosystem, Platinum, Delta Air Lines, Management

Enterprise Connect , the leading conference and exhibition for enterprise communications and customer experience (CX), brought IT decision-makers together to improve business communications and CX.

Key Points: 
  • Enterprise Connect , the leading conference and exhibition for enterprise communications and customer experience (CX), brought IT decision-makers together to improve business communications and CX.
  • “We had an extraordinary week bringing the industry together in person in Orlando and digitally,” said Eric Krapf, General Manager, Enterprise Connect.
  • “For more than 30 years, Enterprise Connect has brought corporate IT decision makers together with industry vendors, analysts, consultants, and channel partners to focus on the issues central to enterprise communications.
  • The Best of Enterprise Connect awards program recognized excellence and innovation in the enterprise communications and customer experience industry.

Nominal Launches with Generative AI to Disrupt the $44B ERP Market

Retrieved on: 
Wednesday, March 27, 2024
Technology, Finance, Venture Capital, Fintech, Accounting, Professional Services, Software, Internet, Data Management, Artificial Intelligence, Financial management, Automation, Intel, Growth, ServiceNow, Veteran, Riskified, Salesforce, ERP, AI, Generative, Engineering, ASC, Multimedia, Leibovitz, ERPs, Gartner, NetApp, CPA, Cryptocurrency

View the full release here: https://www.businesswire.com/news/home/20240327000607/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20240327000607/en/
    Nominal Launches with Generative AI to Disrupt the $44B ERP Market (Photo: Business Wire)
    The $44 billion ERP market (Gartner 2023), originally revolutionized by the cloud, now grapples with outdated systems requiring costly engineering to meet modern companies’ needs.
  • Nominal believes that generative AI is a pivotal technology, especially in light of the decline in CPA candidates and the surge of financial and accounting point solutions.
  • Nominal is poised for rapid mid-market growth by using AI and cloud technology to disrupt the ERP market,” said Nathan Shuchami, managing partner with Hyperwise Ventures.
  • “Nominal leverages AI to deliver a next generation ERP solution purpose-built for mid-market enterprises that includes out-of-the-box integrations and a modern user experience."

SYNERGEN Health Strengthens ASC Offering with Director of Revenue Cycle Consulting

Retrieved on: 
Tuesday, March 26, 2024
Consulting, Data Management, Practice Management, Technology, Professional Services, Health, Payments, Health Technology, Data Analytics, Hospitals, Surgery, Organization, Abdominal ultrasonography, Entrepreneurship, Partner (business rank), Smith, University, MBA, ASC, Grand Canyon University, Colorado State University, Social work, Outpatient surgery, Management

SYNERGEN Health , an industry-leading provider of technology-enabled revenue cycle services and solutions for healthcare organizations, today announced the addition of Patricia Smith as Director of Revenue Cycle Consulting.

Key Points: 
  • SYNERGEN Health , an industry-leading provider of technology-enabled revenue cycle services and solutions for healthcare organizations, today announced the addition of Patricia Smith as Director of Revenue Cycle Consulting.
  • Smith brings more than 25 years of experience in healthcare revenue cycle management and Ambulatory Surgery Center (ASC) operations .
  • SYNERGEN’s holistic approach to ASC revenue cycle management addresses everything from process optimization to AI-driven denial management.
  • To learn more about SYNERGEN Health and its revenue cycle technology solutions and services, visit www.synergenhealth.com or follow us at @SYNERGENHealthLLC on LinkedIn.

Australia Selects BAE Systems and ASC to Build Sovereign Nuclear Powered Submarines

Retrieved on: 
Thursday, March 21, 2024
Defense, Maritime, Transport, Energy, Government Technology, Nuclear, Other Defense, AUKUS, Employment, Government, Joint venture, Royal Navy, ASC Pty Ltd, News, Rolls-Royce, ASC, Atmosphere, Intellectual property, Multimedia, BAE Systems, Arms industry

The Australian Government has selected BAE Systems and ASC Pty Ltd to build Australia's new fleet of nuclear powered submarines in the latest significant development in the AUKUS trilateral security pact between the United States, the United Kingdom and Australia.

Key Points: 
  • The Australian Government has selected BAE Systems and ASC Pty Ltd to build Australia's new fleet of nuclear powered submarines in the latest significant development in the AUKUS trilateral security pact between the United States, the United Kingdom and Australia.
  • View the full release here: https://www.businesswire.com/news/home/20240321327876/en/
    A computer generated image of SSN-AUKUS which will be built for Australia by BAE Systems and ASC Pty Ltd (Photo: Business Wire)
    Australian Deputy Prime Minister, Richard Marles, and UK Defence Secretary, Grant Shapps, announced the news in Australia, marking the next step in the pathway for Australia to build and operate its own nuclear powered submarines.
  • BAE Systems and ASC Pty Ltd will now bring together their complementary skills, expertise and capabilities under a collaborative arrangement in Australia, ultimately leading to the establishment of a long-term, incorporated Joint Venture.
  • The involvement of BAE Systems in Australia ensures an integral connection between the SSN-AUKUS design led by BAE Systems in the UK and the development and maturation of the Australian build strategy.